Integrated Diagnostics Holdings (LSE:IDHC) Market Cap : $188.7 Mil (As of May. 25, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Integrated Diagnostics Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Integrated Diagnostics Holdings's share price for the quarter that ended in Jun. 2023 was $0.4805. Integrated Diagnostics Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 600.0 Mil. Therefore, Integrated Diagnostics Holdings's market cap for the quarter that ended in Jun. 2023 was $288.3 Mil.

Integrated Diagnostics Holdings's quarterly market cap declined from Dec. 2022 ($380.4 Mil) to Mar. 2023 ($276.6 Mil) but then increased from Mar. 2023 ($276.6 Mil) to Jun. 2023 ($288.3 Mil).

Integrated Diagnostics Holdings's annual market cap declined from Dec. 2021 ($771.0 Mil) to Dec. 2022 ($380.4 Mil) and declined from Dec. 2022 ($380.4 Mil) to Dec. 2023 ($213.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Integrated Diagnostics Holdings's Enterprise Value for Today is $195.5 Mil.

Integrated Diagnostics Holdings Market Cap Historical Data

The historical data trend for Integrated Diagnostics Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Market Cap Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

600.00

660.00

771.00

380.40

213.00

Integrated Diagnostics Holdings Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial															456.00	380.40	276.60	288.30	213.00

Competitive Comparison of Integrated Diagnostics Holdings's Market Cap

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrated Diagnostics Holdings's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Market Cap falls into.

Integrated Diagnostics Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Integrated Diagnostics Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$0.355	*	600
	=	$213.0

Integrated Diagnostics Holdings's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	$0.4805	*	600
	=	$288.3

Integrated Diagnostics Holdings (LSE:IDHC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Integrated Diagnostics Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (LSE:IDHC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (LSE:IDHC) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

IDGXF:USA IDHCl:UK IDHC.CA:Egypt 8I8:Germany

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (LSE:IDHC) Headlines

No Headlines